Abbott Laboratories will buy Piramal Healthcare Ltd. ’s branded generic-medicine unit in India for $3.72 billion, making it the country’s biggest drugmaker and tapping into a market expected to more than double by 2015.
Super Religare Laboratories Ltd. , controlled by billionaire brothers Malvinder and Shivinder Singh, agreed to buy Piramal Healthcare Ltd. ’s diagnostics unit for 6 billion rupees ($129 million) to become India’s largest provider of laboratory services.
Piramal Enterprises, the Indian company controlled by Indian billionaire Ajay Piramal, agreed to buy a 20 percent stake in financial-services company Shriram Capital Ltd. for 20.14 billion rupees ($334 million).
Indiareit Fund Advisors Pvt., which manages $1 billion in real estate assets, is delaying its $250 million overseas fundraising plan by six months to focus on investing for new clients won earlier this month.
Vodafone Group Plc’s $1.6 billion plan to buy out the local partners in its Indian unit won government approval, six months after the South Asian nation ended limits on foreign ownership in the sector.